VIMAB Financial Statements From 2010 to 2024
VIMAB Stock | 7.50 0.25 3.23% |
Check VIMAB Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VIMAB Group's main balance sheet or income statement drivers, such as , as well as many indicators such as . VIMAB financial statements analysis is a perfect complement when working with VIMAB Group Valuation or Volatility modules.
VIMAB |
VIMAB Group AB Company Return On Equity Analysis
VIMAB Group's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current VIMAB Group Return On Equity | 2.92 |
Most of VIMAB Group's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VIMAB Group AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Based on the latest financial disclosure, VIMAB Group AB has a Return On Equity of 2.9153. This is much higher than that of the Industrials sector and significantly higher than that of the Consulting Services industry. The return on equity for all Sweden stocks is notably lower than that of the firm.
VIMAB Group AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining VIMAB Group's current stock value. Our valuation model uses many indicators to compare VIMAB Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VIMAB Group competition to find correlations between indicators driving VIMAB Group's intrinsic value. More Info.VIMAB Group AB is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VIMAB Group's earnings, one of the primary drivers of an investment's value.About VIMAB Group Financial Statements
VIMAB Group shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although VIMAB Group investors may analyze each financial statement separately, they are all interrelated. The changes in VIMAB Group's assets and liabilities, for example, are also reflected in the revenues and expenses on on VIMAB Group's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VIMAB Stock Analysis
When running VIMAB Group's price analysis, check to measure VIMAB Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VIMAB Group is operating at the current time. Most of VIMAB Group's value examination focuses on studying past and present price action to predict the probability of VIMAB Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VIMAB Group's price. Additionally, you may evaluate how the addition of VIMAB Group to your portfolios can decrease your overall portfolio volatility.